Kirkpatrick, Andrew W.
McKee, Jessica L.
Conly, John M.
Article History
Received: 7 December 2020
Accepted: 25 May 2021
First Online: 30 May 2021
Declarations
:
: This research was approved by the CHREB of the University of Calgary, REB14-0634_MOD4. Consent for publication. All subjects provided written informed consent after full explanation of the study.
: The research participants freely consent to publication of the main manuscript and Supplementary material.
: Andrew W Kirkpatrick has consulted for the Zoll, Innovative Trauma Care and SAM Medical Corporations, and is the PI of a Prospective Randomized Controlled Trial partially supported by the Acelity Corporation (ExternalRef removed). He discloses a personal relationship with JL McKee. Jessica L McKee is the Research Director of Innovative Trauma Care and has consulted for Zoll, Aceso, SAM Medical Products and Acelity. She also discloses a personal relationship with AW Kirkpatrick. John Conly has served as the local Principal Investigator for the STRIVE study which was a randomized controlled trial of a <i>Staphylococcus aureus</i> vaccine to prevent post-surgical infections following spinal surgery sponsored by Pfizer for which all funds were received by University of Calgary.